These innovative therapies , Retatrutide, represent a significant advancement in treating type 2 diabetes and potentially other ailments . These drugs are classified as GLP-1 receptor stimulators, https://kobiyegr153655.ka-blogs.com/94898735/semaglutide-a-deep-dive-into-metabolic-copyright